51,511 Shares in Aemetis, Inc $AMTX Acquired by State of Wyoming

State of Wyoming bought a new position in shares of Aemetis, Inc (NASDAQ:AMTX) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 51,511 shares of the specialty chemicals company’s stock, valued at approximately $90,000. State of Wyoming owned 0.10% of Aemetis at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wellington Management Group LLP grew its stake in Aemetis by 142.2% in the 1st quarter. Wellington Management Group LLP now owns 62,995 shares of the specialty chemicals company’s stock worth $110,000 after buying an additional 36,983 shares in the last quarter. Nuveen LLC purchased a new position in Aemetis in the 1st quarter worth approximately $153,000. Invesco Ltd. grew its stake in Aemetis by 374.0% in the 1st quarter. Invesco Ltd. now owns 81,256 shares of the specialty chemicals company’s stock worth $141,000 after buying an additional 64,115 shares in the last quarter. PNC Financial Services Group Inc. grew its stake in Aemetis by 14.2% in the 1st quarter. PNC Financial Services Group Inc. now owns 113,560 shares of the specialty chemicals company’s stock worth $198,000 after buying an additional 14,152 shares in the last quarter. Finally, ProShare Advisors LLC purchased a new position in Aemetis in the 4th quarter worth approximately $27,000. Institutional investors own 27.02% of the company’s stock.

Insider Activity

In other news, Director Francis P. Barton sold 26,452 shares of the company’s stock in a transaction on Thursday, August 14th. The shares were sold at an average price of $2.53, for a total value of $66,923.56. Following the completion of the sale, the director owned 208,518 shares of the company’s stock, valued at approximately $527,550.54. This represents a 11.26% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 15.90% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Ascendiant Capital Markets boosted their price target on shares of Aemetis from $19.00 to $20.00 and gave the stock a “buy” rating in a research note on Friday, June 6th. UBS Group boosted their price target on shares of Aemetis from $2.20 to $3.00 and gave the stock a “buy” rating in a research note on Monday, June 30th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average target price of $17.00.

Aemetis Stock Performance

Shares of Aemetis stock opened at $2.26 on Tuesday. Aemetis, Inc has a 52-week low of $1.22 and a 52-week high of $4.73. The stock has a market capitalization of $142.92 million, a price-to-earnings ratio of -1.40 and a beta of 1.34. The company has a fifty day moving average of $2.77 and a 200-day moving average of $2.10.

Aemetis (NASDAQ:AMTX) last announced its quarterly earnings data on Thursday, August 7th. The specialty chemicals company reported ($0.41) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.06). The firm had revenue of $52.24 million for the quarter, compared to the consensus estimate of $78.68 million. On average, equities research analysts forecast that Aemetis, Inc will post -2.07 earnings per share for the current fiscal year.

Aemetis Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.